Regulatory Readiness MB Research Laboratories is a GLP-compliant CRO with a long history in toxicology testing and a focus on regulatory-ready data aligned with OECD, ISO 10993, and U.S. EPA OCSPP guidelines. This positions them as a capable partner for sponsors seeking compliant safety data for medical devices, pharmaceuticals, and consumer products.

NAMs Expertise The company emphasizes New Approach Methodologies and alternative, non-animal assays, including development, validation, and application of NAMs. This presents growth opportunities with sponsors aiming to modernize toxicology programs, reduce animal testing, and meet evolving regulatory expectations.

Scope of Testing Core capabilities cover in vitro toxicology and irritation testing, device biocompatibility per ISO 10993, plus acute and specialized in vivo studies. This broad suite allows cross-category outsourcing for medical devices, pharmaceuticals, chemicals, and consumer products seeking comprehensive safety assessments.

SMB-to-Strategic Upsell With 11-50 employees and revenue in the 1–10 million range, MB Research likely serves mid-market clients. There is a sales opportunity to upsell expanded GLP services, extended NAM programs, and regulatory submissions to growing clients in medical devices and regulated sectors.

Global Compliance Footprint Their experience partnering with industry and government clients worldwide and routine work under global guidelines signals capability to support multinational product pipelines and submissions, making them attractive for sponsors aiming for global regulatory approvals and harmonized toxicology data packages.